Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer
- 1 October 2004
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (15) , 2260-2268
- https://doi.org/10.1016/j.ejca.2004.05.023
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Quality of life after surgical treatment of gastric carcinomaBritish Journal of Surgery, 2003
- Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancerEuropean Journal Of Cancer, 2003
- Randomized Phase II Trial of Either Fluorouracil, Parenteral Hydroxyurea, Interferon-??t-2a, and Filgrastim or Doxorubicin/Docetaxel in Patients with Advanced Gastric Cancer with Quality-of-Life AssessmentThe Cancer Journal, 2002
- Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric CancerJournal of Clinical Oncology, 2002
- Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionNew England Journal of Medicine, 2001
- Development of an EORTC disease-specific quality of life module for use in patients with gastric cancerEuropean Journal Of Cancer, 2001
- The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomyCancer, 2000
- Quality of Life following Radical Surgical Treatment of Gastric CarcinomaWorld Journal of Surgery, 1999
- Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trialThe Lancet, 1996
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993